You are here: Industry Insights > NICE

News List

NICE recommends Roche’s breast cancer drug pertuzumab pharmaceutical-technology
February 19, 2019
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Roche’s Perjeta (pertuzumab) by the National Health Service (NHS) to treat early HER2-positive breast cancer, which has spread to lymph nodes.....
NICE backs Takeda’s Alunbrig in second-line lung cancer pharmaphorum
February 18, 2019
NICE has published final draft guidance recommending regular NHS funding in England for Takeda’s Alunbrig (brigatinib), for ALK-positive advanced non-small cell lung cancer, in patients already treated with Pfizer’s Xalkori.
Price cut unlocks NICE nod for Perjeta in post-surgery breast cancer pharmaphorum
February 15, 2019
Roche has finally won NICE backing for the use of Perjeta (pertuzumab) to prevent early-stage HER2-positive breast cancer from recurring after surgery, at the third attempt.
NICE launches scientific advice tie-up with Canadian agency pharmaphorum
February 14, 2019
The UK’s cost-effectiveness regulator NICE and the its counterpart in Canada have launched a new collaboration to offer parallel scientific advice to the life sciences industry.
NICE recommends NHS use of Kymriah for second indication pharmaceutical-technology
February 03, 2019
The UK’s pricing regulator the National Institute for Health and Care Excellence (NICE) has recommended Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for use by the National Health Service (NHS)
Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company fiercepharma
February 01, 2019
Payer coverage is key to Novartis’ plan to get Kymriah going, and the company is going to be getting some more of that.
NICE assessments could reform in new superbug plan pharmaphorum
January 25, 2019
The UK government has published a new five year plan aimed at tackling antimicrobial resistance (AMR), including a new NHS reimbursement scheme backed by NICE to encourage pharma to develop new antibiotics.
NICE backs digital CBT for youngsters with depression pharmaphorum
January 24, 2019
NICE has recommended digital cognitive behavioural therapy (CBT) should be used as a first-line treatment for children and young people with mild depression.
NICE clears Pierre Fabre's targeted melanoma combo to take on Novartis, Roche drugs fiercepharma
January 22, 2019
Thanks to new guidance from England’s drug cost watchdog, Novartis and Roche will be getting some fresh targeted melanoma competition from French pharma lab Pierre Fabre.
Lilly’s Verzenios approved by NICE pharmaphorum
January 21, 2019
NICE has published draft guidance that now recommends Eli Lilly’s breast cancer drug Verzenios for use on the NHS.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 41 42 Next page